Corrigendum to “Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis” [Cancer Lett. 380 (2016) 87–97](S0304383516303743)(10.1016/j.canlet.2016.06.014)

Yun Xin Lu, Huai Qiang Ju, Feng Wang, Le Zong Chen, Qi Nian Wu, Hui Sheng, Hai Yu Mo, Zhi Zhong Pan, Dan Xie, Tie Bang Kang, Gong Chen, Jing Ping Yun, Zhao Lei Zeng, Rui Hua Xu

Research output: Contribution to journalComment/debate

Abstract

The authors regret that incorrect images appear in Figure 3B and 4D during data arranging processes. In the published Figure 3B, the flow diagram for HCT116 cells at 24 hour after nafamostat mesilate treatment was incorrectly displayed. In the published Figure 4D, the immunoblotting bands of total-ERK and GAPDH in HCT116 and SW1116 cells were from a different experimental group. This correction does not change the conclusions of this manuscript. Now the corrected Figure 3B and 4D are as below. The authors apologize for the inconvenience. [Figure presented]

Original languageEnglish (US)
Number of pages1
JournalCancer Letters
Volume469
DOIs
StatePublished - Jan 28 2020

Fingerprint

HCT116 Cells
Colorectal Neoplasms
Neoplasm Metastasis
Growth
Immunoblotting
Neoplasms
Emotions
nafamostat
corrigendum
Inhibition (Psychology)

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Corrigendum to “Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis” [Cancer Lett. 380 (2016) 87–97](S0304383516303743)(10.1016/j.canlet.2016.06.014). / Lu, Yun Xin; Ju, Huai Qiang; Wang, Feng; Chen, Le Zong; Wu, Qi Nian; Sheng, Hui; Mo, Hai Yu; Pan, Zhi Zhong; Xie, Dan; Kang, Tie Bang; Chen, Gong; Yun, Jing Ping; Zeng, Zhao Lei; Xu, Rui Hua.

In: Cancer Letters, Vol. 469, 28.01.2020.

Research output: Contribution to journalComment/debate

@article{3c67eaaf1d424aef80f1766c635abaf4,
title = "Corrigendum to “Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis” [Cancer Lett. 380 (2016) 87–97](S0304383516303743)(10.1016/j.canlet.2016.06.014)",
abstract = "The authors regret that incorrect images appear in Figure 3B and 4D during data arranging processes. In the published Figure 3B, the flow diagram for HCT116 cells at 24 hour after nafamostat mesilate treatment was incorrectly displayed. In the published Figure 4D, the immunoblotting bands of total-ERK and GAPDH in HCT116 and SW1116 cells were from a different experimental group. This correction does not change the conclusions of this manuscript. Now the corrected Figure 3B and 4D are as below. The authors apologize for the inconvenience. [Figure presented]",
author = "Lu, {Yun Xin} and Ju, {Huai Qiang} and Feng Wang and Chen, {Le Zong} and Wu, {Qi Nian} and Hui Sheng and Mo, {Hai Yu} and Pan, {Zhi Zhong} and Dan Xie and Kang, {Tie Bang} and Gong Chen and Yun, {Jing Ping} and Zeng, {Zhao Lei} and Xu, {Rui Hua}",
year = "2020",
month = "1",
day = "28",
doi = "10.1016/j.canlet.2019.10.001",
language = "English (US)",
volume = "469",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Corrigendum to “Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis” [Cancer Lett. 380 (2016) 87–97](S0304383516303743)(10.1016/j.canlet.2016.06.014)

AU - Lu, Yun Xin

AU - Ju, Huai Qiang

AU - Wang, Feng

AU - Chen, Le Zong

AU - Wu, Qi Nian

AU - Sheng, Hui

AU - Mo, Hai Yu

AU - Pan, Zhi Zhong

AU - Xie, Dan

AU - Kang, Tie Bang

AU - Chen, Gong

AU - Yun, Jing Ping

AU - Zeng, Zhao Lei

AU - Xu, Rui Hua

PY - 2020/1/28

Y1 - 2020/1/28

N2 - The authors regret that incorrect images appear in Figure 3B and 4D during data arranging processes. In the published Figure 3B, the flow diagram for HCT116 cells at 24 hour after nafamostat mesilate treatment was incorrectly displayed. In the published Figure 4D, the immunoblotting bands of total-ERK and GAPDH in HCT116 and SW1116 cells were from a different experimental group. This correction does not change the conclusions of this manuscript. Now the corrected Figure 3B and 4D are as below. The authors apologize for the inconvenience. [Figure presented]

AB - The authors regret that incorrect images appear in Figure 3B and 4D during data arranging processes. In the published Figure 3B, the flow diagram for HCT116 cells at 24 hour after nafamostat mesilate treatment was incorrectly displayed. In the published Figure 4D, the immunoblotting bands of total-ERK and GAPDH in HCT116 and SW1116 cells were from a different experimental group. This correction does not change the conclusions of this manuscript. Now the corrected Figure 3B and 4D are as below. The authors apologize for the inconvenience. [Figure presented]

UR - http://www.scopus.com/inward/record.url?scp=85073514885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073514885&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2019.10.001

DO - 10.1016/j.canlet.2019.10.001

M3 - Comment/debate

C2 - 31623877

AN - SCOPUS:85073514885

VL - 469

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

ER -